IDEAYA Biosciences (IDYA) News Today $20.93 +0.46 (+2.25%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$20.94 +0.00 (+0.02%) As of 09:17 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period IDEAYA Biosciences (IDYA) to Release Earnings on TuesdayMay 5 at 3:06 AM | americanbankingnews.comInvesco Ltd. Has $1.46 Million Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Invesco Ltd. cut its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 63.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 56,691 shares of the company's stock after sellinMay 3 at 3:29 AM | marketbeat.comTower Research Capital LLC TRC Has $495,000 Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Tower Research Capital LLC TRC raised its position in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 338.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 19,242 shares of tMay 2 at 4:15 AM | marketbeat.comIDEAYA Biosciences (IDYA) Projected to Post Quarterly Earnings on TuesdayIDEAYA Biosciences (NASDAQ:IDYA) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-ideaya-biosciences-inc-stock/)May 1, 2025 | marketbeat.comAquatic Capital Management LLC Buys 29,189 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Aquatic Capital Management LLC lifted its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 47.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 91,189 shares of the coMay 1, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Lowers Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Price T Rowe Associates Inc. MD decreased its position in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 3.7% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 3,866,908 shares of the company's stock after selling 148,390 shares during tApril 30, 2025 | marketbeat.comBarclays PLC Boosts Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Barclays PLC lifted its holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 9.7% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 198,756 shares of the company's stock after buying an additional 17,586 sApril 29, 2025 | marketbeat.comIDEAYA Biosciences to Participate in Upcoming May 2025 Investor Relations EventsApril 28, 2025 | prnewswire.comAdage Capital Partners GP L.L.C. Has $30.84 Million Stock Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Adage Capital Partners GP L.L.C. boosted its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 22.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,200,094 shares of tApril 28, 2025 | marketbeat.comIDEAYA Biosciences Grants Stock Options To New Employees Under 2023 Inducement PlanApril 27, 2025 | nasdaq.comGuggenheim Capital LLC Takes Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Guggenheim Capital LLC acquired a new stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 31,389 shares of the companApril 26, 2025 | marketbeat.comComparing IDEAYA Biosciences (NASDAQ:IDYA) and Eagle Pharmaceuticals (NASDAQ:EGRX)April 26, 2025 | americanbankingnews.comIDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)April 25, 2025 | prnewswire.comMarshall Wace LLP Buys 60,361 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Marshall Wace LLP raised its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 23.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 312,666 shares of the company's stock after acquiringApril 25, 2025 | marketbeat.comWalleye Capital LLC Has $548,000 Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Walleye Capital LLC cut its position in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 84.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 21,312 shares of the company's stock after seApril 25, 2025 | marketbeat.comIDEAYA Biosciences (NASDAQ:IDYA) Trading Up 4.8% - What's Next?IDEAYA Biosciences (NASDAQ:IDYA) Trading 4.8% Higher - Here's What HappenedApril 23, 2025 | marketbeat.comRenaissance Technologies LLC Purchases 113,902 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Renaissance Technologies LLC increased its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 66.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 284,267 shares of the company'sApril 21, 2025 | marketbeat.comIDEAYA Biosciences, Inc. (NASDAQ:IDYA) Given Consensus Recommendation of "Moderate Buy" by AnalystsShares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the fifteen ratings firms that are currently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation, twelve have isApril 21, 2025 | marketbeat.comJump Financial LLC Has $2.95 Million Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Jump Financial LLC grew its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 64.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 114,902 shares of the company's stock after purchasing an additional 4April 20, 2025 | marketbeat.comJPMorgan Chase & Co. Has $7.06 Million Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)JPMorgan Chase & Co. increased its position in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 244.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 274,693 shares of the company's stock after buying anApril 19, 2025 | marketbeat.comIdeaya Biosciences: These Prices Are Probably Going To Look Cheap Sooner Than LaterApril 16, 2025 | seekingalpha.comMizuho Securities Sticks to Its Buy Rating for IDEAYA Biosciences (IDYA)April 16, 2025 | markets.businessinsider.comIdeaya Biosciences announces FDA Type D meeting for darovasertib trial designApril 15, 2025 | markets.businessinsider.comIdeaya trial design consisent with guidance, says OppenheimerApril 15, 2025 | markets.businessinsider.comGeode Capital Management LLC Acquires 43,226 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Geode Capital Management LLC increased its stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 2.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,988,681 shares of the company's stock after acqApril 15, 2025 | marketbeat.comIDEAYA Biosciences Announces Successful FDA Type D Meeting on Phase 3 Registrational Trial Design for Darovasertib as Neoadjuvant Therapy for Primary Uveal MelanomaApril 14, 2025 | prnewswire.comFmr LLC Acquires 327,498 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Fmr LLC lifted its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 2.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,963,151 shares of the company's stApril 13, 2025 | marketbeat.comExodusPoint Capital Management LP Sells 343,236 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)ExodusPoint Capital Management LP cut its holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 86.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 52,252 shares of the company's stock aftApril 12, 2025 | marketbeat.comIdeaya Biosciences initiates expansion in IDE397 trialApril 10, 2025 | markets.businessinsider.comIDEAYA Biosciences Announces Phase 1/2 Expansion for IDE397 and Trodelvy® Combination in MTAP-Deletion Urothelial CancerApril 10, 2025 | prnewswire.comIDEAYA Biosciences (NASDAQ:IDYA) Sets New 1-Year Low - Here's What HappenedIDEAYA Biosciences (NASDAQ:IDYA) Sets New 52-Week Low - What's Next?April 9, 2025 | marketbeat.com107,147 Shares in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Acquired by Trexquant Investment LPTrexquant Investment LP bought a new stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 107,147 shares of the company's stock, valued at approximately $2,754,0April 9, 2025 | marketbeat.comNorges Bank Purchases Shares of 520,810 IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Norges Bank acquired a new position in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 520,810 shares of the company's stock, valued at approximately $13,385,000.April 9, 2025 | marketbeat.comVanguard Group Inc. Has $130.51 Million Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Vanguard Group Inc. lifted its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 5.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,078,084 shares of the company's stock after purcApril 9, 2025 | marketbeat.comFederated Hermes Inc. Trims Stock Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Federated Hermes Inc. cut its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 2.8% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 5,063,526 shares of the company's stock after selling 144,77April 8, 2025 | marketbeat.comRhenman & Partners Asset Management AB Reduces Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Rhenman & Partners Asset Management AB trimmed its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 35.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 82,000 shares of the company's stock afteApril 7, 2025 | marketbeat.comB. Metzler seel. Sohn & Co. AG Invests $701,000 in IDEAYA Biosciences, Inc. (NASDAQ:IDYA)B. Metzler seel. Sohn & Co. AG purchased a new stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 27,276 shares of tApril 7, 2025 | marketbeat.comMitsubishi UFJ Asset Management Co. Ltd. Sells 30,870 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Mitsubishi UFJ Asset Management Co. Ltd. trimmed its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 81.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,856 sharesApril 5, 2025 | marketbeat.comPrudential Financial Inc. Purchases 18,000 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Prudential Financial Inc. raised its position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 21.4% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 101,935 shares of the company's stock after purchasing an additional 18,000 shares during the peApril 5, 2025 | marketbeat.comIDEAYA Biosciences (NASDAQ:IDYA) Trading Up 4.7% - Still a Buy?IDEAYA Biosciences (NASDAQ:IDYA) Shares Up 4.7% - Time to Buy?April 4, 2025 | marketbeat.comIDEAYA Biosciences (NASDAQ:IDYA) Stock Price Down 7.8% - Time to Sell?IDEAYA Biosciences (NASDAQ:IDYA) Stock Price Down 7.8% - Should You Sell?April 3, 2025 | marketbeat.comLeerink Partners Sticks to Their Hold Rating for IDEAYA Biosciences (IDYA)April 2, 2025 | markets.businessinsider.comWhy Ideaya Biosciences Is Down Despite Many PositivesApril 2, 2025 | seekingalpha.comIDEAYA Biosciences Becomes Oversold (IDYA)April 2, 2025 | nasdaq.comIDEAYA Biosciences Announces Participation in Upcoming April 2025 Investor Relations EventsApril 1, 2025 | prnewswire.comIdeaya Biosciences granted breakthrough therapy designation for darovasertibMarch 31, 2025 | markets.businessinsider.comIDEAYA Biosciences Receives US FDA Breakthrough Therapy Designation for Darovasertib Monotherapy in Neoadjuvant Uveal MelanomaMarch 31, 2025 | prnewswire.comPictet Asset Management Holding SA Acquires 46,931 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA)Pictet Asset Management Holding SA increased its holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 2.5% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,941,271 shares of the company's stMarch 31, 2025 | marketbeat.comIDEAYA Biosciences (NASDAQ:IDYA) Hits New 1-Year Low - Time to Sell?IDEAYA Biosciences (NASDAQ:IDYA) Sets New 52-Week Low - Should You Sell?March 29, 2025 | marketbeat.comIDEAYA Biosciences, Inc. (NASDAQ:IDYA) Shares Bought by BIT Capital GmbHBIT Capital GmbH lifted its holdings in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 85.0% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 63,672 shares of the company's stock after purchasing an additional 29,259March 28, 2025 | marketbeat.com Get IDEAYA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IDYA and its competitors with MarketBeat's FREE daily newsletter. Email Address IDYA Media Mentions By Week IDYA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IDYA News Sentiment▼1.210.73▲Average Medical News Sentiment IDYA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IDYA Articles This Week▼86▲IDYA Articles Average Week Get IDEAYA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IDYA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BridgeBio Pharma News TG Therapeutics News Legend Biotech News Sarepta Therapeutics News Telix Pharmaceuticals Limited American Depositary Shares News ADMA Biologics News Blueprint Medicines News Verona Pharma News Nuvalent News Axsome Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IDYA) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IDEAYA Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IDEAYA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IDYA Stock Free IDYA Stock Alerts